We present a retrospective review of twelve cases of Irukandji syndrome associated with pulmonary oedema. This is a life-threatening envenoming due to a presumed jellyfish sting throughout Northern Australia, although only one case occurred outside North Queensland.
The deaths last year of a 58-year-old British and a 44-year-old American tourist who both developed Irukandji syndrome whilst swimming on the Great Barrier Reef have highlighted the lack of knowledge of this jellyfish envenoming. Both men died of intracerebral haemorrhages shortly after developing symptoms, and were the first deaths reported due to this syndrome. Irukandji syndrome is a common presentation to medical facilities in Northern Australia. During the summer 2001/02 in Cairns, 116 patients presented to the Emergency Department with Irukandji syndrome, with beaches being closed for three weeks over the Christmas holidays. We are aware of other Australian cases during the summers 2001/02 and 2002/03 occurring in Karratha, Broome, coastal communities in the Kimberley, Darwin and Groote Island (off the Northern Territory), and the Whitsunday Islands. In 1996, sixty-two patients presented with Irukandji syndrome to hospitals in Cairns 1 . Very little is known about the toxin or the responsible jellyfish, Carukia barnesi, however it is now believed that more than one jellyfish can produce this syndrome 1, 2 .
The Irukandji syndrome was first named by Dr Hugo Flecker in Cairns in 1952 3 , but it was not until 1961 that Dr Jack Barnes 4 was able to catch the jellyfish now known as Carukia barnesi. He demonstrated that this jellyfish caused Irukandji syndrome by stinging himself, his nine-year-old son and the lifeguard on duty at the beach.
Symptoms of Irukandji syndrome 1,2,4 often develop after a minor sting and a delay of 10 to 40 minutes. Symptoms include severe backache, muscle pains, chest and abdominal pain, nausea and vomiting, headache and sweating. Patients are often hypertensive on presentation.
Since 1987 there have been a small number of patients reported to have developed pulmonary oedema in association with Irukandji syndrome symptoms 1,2,5-10 . This has been described in the literature as a severe form of Irukandji syndrome 7 , or "severe Irukandji syndrome" (SIS), although the jellyfish known as the "Irukandji jellyfish" Carukia barnesi has never been shown to be the causal agent.
The aim of this paper is to review all published cases 2,5-10 of severe Irukandji Syndrome as well as cases we have managed. We reviewed the presentation, management and outcome of these cases in an attempt to better elucidate the epidemiology of the condition, and recommend a treatment plan for these patients.
METHODS
A Medline search was performed to identify all reports of Irukandji syndrome, in particular Irukandji syndrome associated with pulmonary oedema. All articles identified by Medline and further articles were identified from their reference lists. New cases were identified by the authors as patients they had treated and not reported.
A pre-designed pro-forma was used to collate data from these case reports.
RESULTS
Since 1987 there have been nine case reports 2,5-10 of Irukandji syndrome associated with pulmonary oedema. We have been associated with three other cases (two in the Cairns region, one case in Broome, W.A., 2001) and we present a summary of all cases in Table 1 .
Of the twelve patients identified, seven were female, eight aged in their teens and twenties with the ages ranging from a seven-year-old boy to a 58-yearold man. Only one of the patients was stung outside of North Queensland (Broome, W.A., 2001). No case occurred early in the stinger season (October/ November), but six cases occurred towards the end of the season (March/April). The envenoming organism was not identified in any case, and in only one case 8 , a 2 mm tentacle was recovered from the patient. This tentacle was identified as not being from Carukia barnesi, although the identity of the jellyfish from the tentacle is yet to be determined.
Clinical presentation & progression
As this was a retrospective review, information was often incomplete. The condition of the patients is presented where reported. A summary of the cases is presented in Table 1 .
Eleven patients were reported in considerable pain and 63% of these required large (>3 mg/kg pethidine or >0.3 mg/kg morphine) and repeated doses of opiates to control the pain.
All patients (N=11), were initially tachycardic and hypertensive, with 67% (N=9) becoming hypotensive, requiring inotrope support. Nonspecific ECG changes occured in 70% (N=10) and cardiac enzyme (either CK or troponin) elevation in 78% (N=9).
Patients developed clinical or radiological evidence of pulmonary oedema 1.5 to 18 hours post sting (mean=14 hours, with 60% patients developing pulmonary oedema in 10 or less hours). All patients had chest X-ray changes consistent with pulmonary oedema.
Eight patients had cardiac echocardiograms performed. All demonstrated global hypokinesis and reduced cardiac output.
Three patients had a pulmonary artery catheter placed (cases 3, 10, 11) Accurate data is available from two cases ( Table 2) .
Management
All patients were admitted to hospital with four requiring intubation and ventilation, and a further two requiring continuous positive airway pressure (CPAP). The longest admission was patient 10 who spent 14 days in hospital with 11 days in ICU. There was one death reported in these cases, due to intracerebral haemorrhage.
Hypertension was treated in five patients, one received a hydrallazine infusion (case 1), three patients received phentolamine infusions (cases 4, 9 and 12) and one patient received propanolol 80 mg (case 7). In this case this patient became hypotensive (BP 60/25 mmHg and required active resuscitation with intravenous colloid and dopamine as an inotrope).
Hypotension was reported in six patients, and in these cases dopamine, dobutamine and/or adrenaline were used as inotropes. In two cases dopamine was successfully used on its own, and in one case it was successfully added to the inotropic regimen (dobutamine). In three cases dobutamine was the initial inotrope, but in two of these another inotrope was added due to persisting hypotension (cases 9 and 10). The use of adrenaline in two cases (cases 10 and 11) did not cause the patients' condition to deteriorate. In both these patients who had pulmonary catheters placed, adrenaline was used as the inotrope of choice and the cardiac index improved and systemic vascular resistance index, and pulmonary artery wedge pressure fell within four to six hours.
DISCUSSION
This article has reviewed twelve cases of severe Irukandji syndrome. It is important to note that neither Barnes 4 nor Flecker 3 reported the occurrence of pulmonary oedema associated with Irukandji syndrome. There has not been any evidence that the "Irukandji" jellyfish, Carukia barnesi, was the offending species. However during the summer 2001/2002 we have seen one patient who had Carukia barnesi nematocysts recovered from his skin, and he developed Irukandji syndrome with ECG changes, troponin rise and a reduction in cardiac output (ejection fraction 30%). He did not develop pulmonary oedema and he recovered 6 . We have reported one case of severe Irukandji syndrome where a 2 mm section of non Carukia barnesi tentacle was found 8 , and in one of the patients who died this summer non Carukia barnesi nematocysts were identified 6 (J. Seymour, personal communication). It is possible that a variety of species of jellyfish may cause severe Irukandji syndrome.
Seasonality
The majority of cases have occurred in young adults with no case occurring early in the stinger season (October/November), and six cases occurring towards the end of the season (March/April). It is possible that venom variation in cubozoans occurs with age of the jellyfish. For example, in Chironex fleckeri, the amount of venom lethal to humans increases dramatically once the animals measure more than 60 to 80 mm in body length 11 . As cases 10 and 11 were remarkably similar both clinically and in laboratory investigations (including pulmonary artery catheter findings), and occurred in both eastern and western waters of tropical Australia, it suggests the causative jellyfish (or toxin) may be found throughout northern Australia. In one case (Broome, W.A.), a second person was envenomed at the same time and in close proximity (less than one metre) to the patient developing severe Irukandji syndrome. The second person did not develop respiratory or cardiac complications and presented with Irukandji syndrome.
One possibility is that venom originating from different areas of the jellyfish, namely tentacles or bell, may give rise to different severity of the syndrome. It is known that the nematocysts (or stinging cells) of jellyfish often contain different types of venoms and are used for different ecological functions, such as prey capture or defence 12 . For example, Chironex fleckeri possesses six different types of nematocysts, with only one thought to contain the venom which is lethal to humans 13, 14 . Carukia barnesi possesses three distinct types of nematocysts, two types on the tentacles and one on the bell 14 . Similar scenarios also exists for other jellyfish thought to be responsible for producing Irukandji syndrome (J. Seymour, unpublished data).
Cause of symptoms
The cause of the symptoms of Irukandji syndrome is unclear. Some authors feel that the cause may be due to a toxin-mediated release of catecholamines 2,7,10,23 . Although it is possible that a massive release of catecholamines may result in pulmonary oedema, it is difficult to say whether the release of catecholamines is solely due to the toxin directly 2, 7, 10 or in response to the pain or cardiac dysfunction 5, 8 .
We postulate that a toxin responsible for severe Irukandji Syndrome acts directly on the myocardium. Patients in our series had features that could be consistent with myocarditis 15 . The clinical features of myocarditis are varied. All patients developed clinical and radiological evidence of cardiac failure associated with a persisting tachycardia. The majority of patients had derangement in ECG and elevation in cardiac enzymes. All who had cardiac echocardiography performed demonstrated global hypokinesis with reduced cardiac output. The two patients who had pulmonary artery catheters placed had further confirmatory evidence to suggest cardiac failure ( Table 2) .Toxic myocarditis has been reported in scorpion, snake and spider bites 15 .
Other jellyfish toxins have demonstrated cardiac toxicity. The mode of death in humans 16 , and pigs 17 by the Chironex fleckeri venom is believed due to cardiac depression. Humans have developed pulmonary oedema with envenomations due to Chironex fleckeri 18 . In an animal study 19 within 30 seconds of injecting venom from Chiropsalmus sp jellyfish (a closely related genus to Chironex) into prawns, there was a 75% reduction in the prawn heart rate, with cardiac standstill occurring within 60 seconds.
Management
There have not been any controlled studies to determine best management of these patients. Clearly attention should be initially directed to airway, breathing and circulation. The sting site should be bathed in vinegar for at least 30 seconds.
The use of pressure immobilization bandages in the treatment of jellyfish stings remains controversial. We do not advocate their use, as we have demonstrated increased release of toxin from the nematocysts with pressure equal to bandage pressures 19 . The Australian Resuscitation Council has recently changed its recommendations, and reduced emphasis on the role of pressure immobilization bandages in first aid 20 .
Opiates have been used for pain relief. Barnes 4 initially recommended the use of pethidine in the treatment of Irukandji syndrome; however with such large doses being used pethidine has the increased risk of causing myocardial depression and neurotoxicity 1 . Therefore we do not currently recommend it 16 . Both morphine and fentanyl 1,2 have been recommended and used for pain relief with no obvious adverse reaction. As fentanyl does not cause histamine release and is less likely to cause hypotension there are theoretical grounds for this to be used initially for pain relief 22 .
Patients with ongoing pain appear more likely to develop evidence of cardiac injury. Patients should be appropriately monitored and investigated. It is important to note that one patient with severe and ongoing pain developed pulmonary oedema within 90 minutes of the sting. The management of the initial hypertension remains controversial. In the reviewed cases all patients required large doses of opiate analgesia for pain relief. It is important that the pain is adequately controlled, as this will contribute to the hypertension.
Due to presumed catecholamine excess, phentolamine has been suggested for its alpha blocking effect and short half-life 2, 5, 10 . This drug is rarely used in rural hospitals and may not be available. Although it is important to treat hypertension when associated with cardiac dysfunction (such as cardiac failure), any antihypertensive used should be used with caution. In the reviewed cases, the treatment of hypertension (case 2) with a beta-blocker resulted in significant hypotension which required correction. We believe that intravenous nitrates should be used, as they are commonly available and regularly used in rural hospitals and can be easily titrated.
It is important to note in cases 10 and 11, where a pulmonary artery catheter was placed, patients had a high systemic vascular resistance index and reduced cardiac output. The introduction of a peripheral vasodilator could have resulted in significant hypotension.
Extreme caution should therefore be exercised, and the patient should have appropriate monitoring including the use of invasive haemodynamic monitoring and echocardiography as required. Agents used should be short-acting so that adverse effects may be readily aborted 8, 21 .
If hypotension occurs and support is required, we have found adrenaline to be the most effective inotrope.
A recent report has described a case of Irukandji syndrome successfully treated with intravenous magnesium 24 . The patient's symptoms had not settled with 27.5 mg of morphine and 15 mg diazepam, but there was a marked resolution in symptoms with the initial bolus of 10 mmol of magnesium. Early reduction of the magnesium infusion resulted in recrudencence of symptoms. Anecdotal observations from patients with Irukandji syndrome treated in Cairns with magnesium has confirmed this observation, although further research is required.
Terminology
In marine envenoming literature, the terminology associated with Irukandji syndrome is confusing. Barnes himself named a "pseudo Irukandji syndrome" for milder forms of this disease 25 . As Carukia barnesi is known as the Irukandji jellyfish, it has been assumed that this jellyfish is responsible for all stings resulting in Irukandji syndrome. As there is evidence that there is more than one jellyfish responsible for Irukandji syndrome, we believe Carukia barnesi should be known as the "Barnes jellyfish".
We believe that the term severe Irukandji syndrome should be replaced. Neither Barnes 4 nor Flecker 3 reported pulmonary oedema in their classical descriptions of Irukandji syndrome. As yet a Carukia barnesi sting has not been identified in patients developing pulmonary oedema, although we have seen a patient with C. Barnesi sting develop significant cardiac dysfunction. Cases have occurred where as yet unknown jellyfish other than Carukia barnesi have caused pulmonary oedema 8 . Furthermore the deaths due to intercerebral haemorrhage are clearly a severe complication.
We therefore propose that a new case definition. Cardiotoxic marine envenoming should be used to describe a patient who has been stung by a jellyfish, develops no or minimal skin markings, but develops symptoms of Irukandji syndrome as well as developing evidence of pulmonary oedema.
CONCLUSION
It is possible that some jellyfish or toxin found throughout northern Australia, other than Carukia barnesi, is responsible for the development of pulmonary oedema, in patients who have clinical features consistent with cardiomyopathy.
Patients are in considerable pain and require large doses of opiate. As there is theoretical evidence that fentanyl in large doses causes less cardiovascular instability compared with other opiates, we believe this should be the opiate of choice.
We would advocate the use of intravenous nitrates to control hypertension, but extreme caution should be exercised. Patients should have appropirate invasive monitoring and cardiac echocardiography as required.
Anecdotal experience of intravenous magnesium suggests that it may be effective in controlling symptoms associated with Irukandji syndrome.
Inotropes were required in six patients and in our experience adrenaline, has been an effective inotrope 8 .
As there is confusion in the literature, it is proposed that Carukia barnesi be known as the Barnes jellyfish, and the development of pulmonary oedema in associated with Irukandji syndrome should not be called severe Irukandji syndrome, but rather cardiotoxic marine envenoming.
